Free Trial

Biogen (BIIB) SEC Filings & 10K Form

Biogen logo
$140.64 +3.56 (+2.60%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$140.62 -0.02 (-0.02%)
As of 02/21/2025 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Biogen SEC Filings

DateFilerForm TypeView
02/12/2025
4:40 PM
Biogen (Issuer)
Izzar Rachid (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
4:42 PM
ALEXANDER SUSAN H (Reporting)
Biogen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
4:43 PM
Biogen (Issuer)
Gregory Ginger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
4:44 PM
Biogen (Issuer)
Kramer Robin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
4:46 PM
Biogen (Issuer)
MCDONNELL MICHAEL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
4:47 PM
Biogen (Issuer)
Murphy Nicole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
4:48 PM
Biogen (Issuer)
Singhal Priya (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
4:28 PM
Biogen (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/12/2025
6:06 AM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2025
8:52 PM
Biogen (Issuer)
Izzar Rachid (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
5:55 PM
Biogen (Issuer)
Viehbacher Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
5:59 PM
Biogen (Issuer)
MCDONNELL MICHAEL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
5:42 PM
ALEXANDER SUSAN H (Reporting)
Biogen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
5:44 PM
Biogen (Issuer)
Gregory Ginger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
5:45 PM
Biogen (Issuer)
Singhal Priya (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
5:47 PM
Biogen (Issuer)
Murphy Nicole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
5:48 PM
Biogen (Issuer)
Kramer Robin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
5:49 PM
Biogen (Issuer)
Izzar Rachid (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
5:51 PM
Biogen (Issuer)
Keeney Adam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
5:52 PM
Biogen (Issuer)
Grogan Jane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
5:02 PM
Biogen (Issuer)
Singhal Priya (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2025
7:00 AM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
4:34 PM
Biogen (Filed by)
Sage Therapeutics, Inc. (Subject)
Form SCHEDULE 13D
01/07/2025
3:14 PM
Biogen (Issuer)
Pangalos Menelas N (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/09/2024
3:56 PM
Biogen (Issuer)
Kramer Robin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
3:57 PM
Biogen (Issuer)
Singhal Priya (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
9:33 AM
Biogen (Subject)
Singhal Priya (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/07/2024
3:23 PM
ALEXANDER SUSAN H (Reporting)
Biogen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2024
10:20 AM
Biogen (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/30/2024
3:45 PM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2024
3:31 PM
Biogen (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/30/2024
5:55 AM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2024
11:11 AM
Biogen (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
10/07/2024
6:08 PM
Biogen (Issuer)
Minor Lloyd (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
6:31 AM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2024
5:00 AM
Biogen (Issuer)
Singhal Priya (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
12:00 PM
Biogen (Subject)
Singhal Priya (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/16/2024
5:40 PM
Biogen (Filed by)
SANGAMO THERAPEUTICS, INC (Subject)
Form SC 13G/A
08/01/2024
5:55 AM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2024
4:01 PM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2024
4:06 PM
Biogen (Issuer)
DORSA CAROLINE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Collect $7k per month from Tesla’s SECRET dividend (Ad)

There's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a traditional dividend, there's a way to collect up to $7,013 per month from Tesla… starting as early as next month. This backdoor strategy is changing the game for smart investors. Want to see how it works?

Click here to uncover Tesla's hidden income secret.
06/25/2024
4:13 PM
Biogen (Issuer)
Freire Maria C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
4:14 PM
Biogen (Issuer)
HAWKINS WILLIAM A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
4:15 PM
Biogen (Issuer)
Patolawala Monish D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
4:16 PM
Biogen (Issuer)
LANGER SUSAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
4:18 PM
Biogen (Issuer)
Rowinsky Eric K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
4:19 PM
Biogen (Issuer)
Mantas Jesus B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
4:20 PM
Biogen (Issuer)
SHERWIN STEPHEN A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
4:08 PM
Biogen (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/03/2024
7:00 PM
Biogen (Issuer)
Keeney Adam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/26/2024
4:15 PM
Biogen (Filer)
Form ARS
04/24/2024
3:15 PM
Biogen (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/24/2024
6:02 AM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/12/2024
4:01 PM
Biogen (Filer)
Form PRE 14A
04/03/2024
7:24 PM
Biogen (Issuer)
Singhal Priya (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
7:11 PM
Biogen (Issuer)
Murphy Nicole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
9:08 AM
Biogen (Subject)
Singhal Priya (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2024
6:54 PM
Biogen (Issuer)
Singhal Priya (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
9:12 AM
Biogen (Subject)
Singhal Priya (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:BIIB) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners